Kaiyuan Ji Selected Research

Neoplasms (Cancer)

1/2023	The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer.
6/2022	Correction to "Light-Induced Reactive Oxygen Species (ROS) Generator for Tumor Therapy through an ROS Burst in Mitochondria and AKT-Inactivation-Induced Apoptosis".
1/2021	The role of S-nitrosylation of PFKM in regulation of glycolysis in ovarian cancer cells.
1/2021	Light-Induced Reactive Oxygen Species (ROS) Generator for Tumor Therapy through an ROS Burst in Mitochondria and AKT-Inactivation-Induced Apoptosis.
1/2019	A miRNA-HERC4 pathway promotes breast tumorigenesis by inactivating tumor suppressor LATS1.
11/2018	Differential expression of lncRNAs and predicted target genes in normal mouse melanocytes and B16 cells.
1/2018	Artemisitene suppresses tumorigenesis by inducing DNA damage through deregulating c-Myc-topoisomerase pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kaiyuan Ji Research Topics

Disease

7	Neoplasms (Cancer) 01/2023 - 01/2018
4	Carcinogenesis 01/2023 - 01/2018
3	Hypoxia (Hypoxemia) 01/2024 - 01/2021
3	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2019
3	Melanoma (Melanoma, Malignant) 06/2019 - 04/2016
2	Inflammation (Inflammations) 01/2023 - 01/2021
1	Premature Birth (Birth, Premature) 01/2024
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Nasopharyngeal Carcinoma 01/2023
1	Hemorrhage 01/2022
1	Ductal Carcinoma 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Experimental Melanoma 11/2018
1	Sarcoma (Soft Tissue Sarcoma) 10/2018
1	Infections 01/2018
1	Stomach Neoplasms (Stomach Cancer) 01/2017
1	Microphthalmos 09/2016

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2016
4	Messenger RNA (mRNA)IBA 01/2023 - 04/2016
3	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2021
3	Melanins (Melanin)IBA 06/2019 - 09/2016
3	Monophenol Monooxygenase (Tyrosinase)IBA 06/2019 - 09/2016
2	ChromatinIBA 01/2024 - 12/2022
2	CytokinesIBA 01/2023 - 01/2021
2	Small Interfering RNA (siRNA)IBA 12/2022 - 06/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2022 - 01/2021
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2019 - 01/2018
1	OligonucleotidesIBA 01/2024
1	Adenosine Triphosphate (ATP)IBA 01/2024
1	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2024
1	6-methyladenineIBA 01/2023
1	N-methyladenosineIBA 01/2023
1	RNA Helicases (RNA Helicase)IBA 01/2023
1	Retinoic Acid Receptor gammaIBA 01/2023
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2023
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2022
1	2-MethoxyestradiolIBA 12/2022
1	Competitive Endogenous RNAIBA 01/2022
1	CarbonIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	ProteomeIBA 01/2021
1	Nitrogen OxidesIBA 01/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 06/2019
1	Cyclin-Dependent Kinase 5IBA 06/2019
1	IntegrinsIBA 06/2019
1	NF-kappa B (NF-kB)IBA 11/2018
1	Long Noncoding RNAIBA 11/2018
1	Transforming Growth Factor beta (TGF-beta)IBA 11/2018
1	Microphthalmia-Associated Transcription FactorIBA 10/2018
1	Myosins (Myosin)IBA 10/2018
1	pheomelaninIBA 10/2018
1	AlkaliesIBA 10/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018
1	Antimalarials (Antimalarial Agents)IBA 01/2018
1	EpitopesIBA 01/2018
1	artemisiteneIBA 01/2018
1	artemisinin (artemisinine)IBA 01/2018
1	Anoctamin-1IBA 01/2017
1	ImmunosorbentsIBA 01/2017
1	LuciferasesIBA 01/2017
1	EnzymesIBA 01/2017
1	Transcription Factors (Transcription Factor)IBA 09/2016

Therapy/Procedure

5	Therapeutics 01/2024 - 01/2018
1	Drug Therapy (Chemotherapy) 01/2018